Ischemic cardiomyopathy
Conditions
Interventions
Control group:Tandardized treatment of ischemic cardiomyopathy
Experimental group:Hongqi Shenmai Decoction was added on the basis of standardized treatment of ischemic cardiomyopathy
Sponsors
Jiangsu Province Hospital of Integration of Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Consistent with the Chinese medicine and Western medicine of diagnostic criteria of ischemic cardiomyopathyand the Chinese medicine diagnosis is deficiency of qi and yin and blood stasis and obstruction of collaterals. 2.Aged 18-80 years no gender limit; 3.Volunteer to participate in the study agree and sign a written informed consent form; 4.During the study observation period those who actively cooperated and followed the doctor's instructions to take the regular medication on time and in accordance with the dosage; 5.Able to follow up consistently within six months.
Exclusion criteria
Exclusion criteria: 1.Combination of other heart diseases such as rheumatic heart disease and anemic heart disease; 2.Patients with combined acute myocardial infarction; 3.Relevant clinical information is incomplete and missing; 4.Patients transferred to other medical institutions due to medical conditions during hospitalization; 5.Patients who give up rescue; 6.Other patients whom the investigator considers inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Echocardiogram;Renal function;Blood fat;Heart function classification; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events;Chinese medicine symptom complex score; | — |
Countries
China
Contacts
Public ContactWang Xindong
Jiangsu Province Hospital of Integration of Chinese and Western Medicine
Outcome results
None listed